These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 237416)

  • 1. In line final filters for removing particles from amphotericin B infusions.
    Huber RC; Riffkin C
    Am J Hosp Pharm; 1975 Feb; 32(2):173-6. PubMed ID: 237416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Particulate matter in reconstituted amphotericin B and assay of filtered solutions of amphotericin B.
    Piecoro JJ; Goodman NL; Wheeler WE; Gwilt PR; Rapp RP
    Am J Hosp Pharm; 1975 Apr; 32(4):381-4. PubMed ID: 1093398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Availability of active amphotericin B after filtration through membrane filters.
    Tripple M; Shadomy S; Espinel-Ingroff A
    Am Rev Respir Dis; 1977 May; 115(5):879-81. PubMed ID: 857722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the in-line filters for the intravenous infusion of amphotericin B fluid.
    Hirakawa M; Makino K; Nakashima K; Kataoka Y; Oishi R
    J Clin Pharm Ther; 1999 Oct; 24(5):387-92. PubMed ID: 10583703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of amphotericin B in four concentrations of dextrose injection.
    Wiest DB; Maish WA; Garner SS; el-Chaar GM
    Am J Hosp Pharm; 1991 Nov; 48(11):2430-3. PubMed ID: 1746578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Filtering effectiveness of conventional 15 m micron filters (DIN 58362) and newly developed 15 m micron and 5 m micron filters. I: Particle count].
    Walpot H; Franke RP; Burchard WG; Agternkamp C; Müller FG; Mittermayer C; Kalff G
    Infusionstherapie; 1989 Apr; 16(2):77-80. PubMed ID: 2737765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane filtration of pharmaceutical solutions.
    McKinnon BT; Avis KE
    Am J Hosp Pharm; 1993 Sep; 50(9):1921-36. PubMed ID: 8135243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consequences of microbial contamination during extended intravenous therapy using inline filters.
    Rusmin S; Althauser MB; DeLuca PP
    Am J Hosp Pharm; 1975 Apr; 32(4):373-7. PubMed ID: 805533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality evaluation by capillary electrophoresis of amphotericin B injection after filtration through various membrane filters.
    Makino K; Hirakawa M; Goto Y; Nakashima K; Kataoka Y; Oishi R
    Electrophoresis; 1998 Nov; 19(16-17):2930-4. PubMed ID: 9870391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of LDH activity during membrane filtration.
    Nema S; Avis KE
    J Parenter Sci Technol; 1993; 47(1):16-21. PubMed ID: 8445493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sorption of bacterial endotoxin and retention of bacteria by positively charged membrane filters.
    van Doorne H
    J Parenter Sci Technol; 1993; 47(5):192-8. PubMed ID: 8263658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Particulate contamination of lyophilized amphotericin B preparation during reconstitution process.
    Sendo T; Hirakawa M; Makino K; Nakashima K; Kataoka Y; Oishi R
    J Clin Pharm Ther; 2001 Apr; 26(2):87-91. PubMed ID: 11350530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micron-pore-sized metallic filter tube membranes for filtration of particulates and water purification.
    Phelps TJ; Palumbo AV; Bischoff BL; Miller CJ; Fagan LA; McNeilly MS; Judkins RR
    J Microbiol Methods; 2008 Jul; 74(1):10-6. PubMed ID: 17884208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contamination of 0.2-micrometer infusion filters by N,N-dimethylacrylamide.
    Gasch J; Oertel R; Leopold CS; Knoth H
    J Crit Care; 2010 Mar; 25(1):172.e9-14. PubMed ID: 19682842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric membrane filters for the removal of leukocytes from blood.
    Bruil A; van Aken WG; Beugeling T; Feijen J; Steneker I; Huisman JG; Prins HK
    J Biomed Mater Res; 1991 Dec; 25(12):1459-80. PubMed ID: 1794995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of filtration on the presence of particulate and oxycodone content of injections prepared from crushed OxyContin® tablets.
    Patel P; Patel RP; Brandon S; McLean S; Bruno R; de Graaff B
    Curr Drug Saf; 2012 Jul; 7(3):218-24. PubMed ID: 22950988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical guidelines for preparing and administering amphotericin B.
    Kintzel PE; Smith GH
    Am J Hosp Pharm; 1992 May; 49(5):1156-64. PubMed ID: 1595747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sepsis in rabbits following administration of contaminated infusions through filters of various pore sizes.
    Rapp RP; Bivins BA; DeLuca P
    Am J Hosp Pharm; 1979 Dec; 36(12):1711-3. PubMed ID: 525650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approaches to reducing subvisible particle counts in lyophilized parenteral formulations.
    Gupta PK; Porembski E; Williams NA
    J Pharm Sci Technol; 1994; 48(1):30-7. PubMed ID: 8004415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scrapie removal using Planova virus removal filters.
    Tateishi J; Kitamoto T; Mohri S; Satoh S; Sato T; Shepherd A; Macnaughton MR
    Biologicals; 2001 Mar; 29(1):17-25. PubMed ID: 11482889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.